SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-17-000125
Filing Date
2017-05-15
Accepted
2017-05-15 14:31:09
Documents
1
Period of Report
2017-05-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 2997
  Complete submission text file 0001192482-17-000125.txt   4639
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Issuer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 34TH STREET AND CIVIC CENTER BOULEVARD PHILADELPHIA PA 19004
Business Address 34TH STREET AND CIVIC CENTER BOULEVARD PHILADELPHIA PA 19004 267-426-6957
Children's Hospital of Philadelphia Foundation (Reporting) CIK: 0001632060 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 0630
Type: 4 | Act: 34 | File No.: 001-36819 | Film No.: 17843353